Aug 12, 2020
NS Pharma's VILTEPSO(TM) (viltolarsen) injection Now FDA-Approved in the U.S. for the Treatment of Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy
Jun 09, 2020
CureDuchenne Ventures Announces The "CureDuchenne Ventures 2020 Pitch Contest," To Award Two $25,000 Prizes For Novel Ideas In Duchenne Muscular Dystrophy Therapy Development
May 26, 2020
NS Pharma Announces Publication of Clinical Trial Data for Viltolarsen in DMD Patients in JAMA Neurology
Dec 18, 2019
Parent Project Muscular Dystrophy Awards $465,000 Grant to The Ohio State University to Rescue Cardiac Dystrophin & Function in Duchenne Muscular Dystrophy
Dec 13, 2019
MDA Celebrates FDA Approval of Vyondys 53 for Treatment of DMD Amenable to Exon 53 Skipping
Dec 12, 2019
FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation
Nov 05, 2019
Dystrogen Therapeutics Announces That Treatment With Dystrophin Expressing Chimeric (DEC) Cells Improves Cardiac Function in Preclinical Duchenne's Study
Sep 17, 2019
Positive preliminary results from ATL1102 for DMD Phase II trial
Sep 17, 2019
PPMD Awards University of Florida $1 Million for Novel Gene Therapy Approach Targeting the Heart
Sep 05, 2019
Muscular Dystrophy Association Awards 25 Grants Totaling More Than $6.6 Million for Neuromuscular Disease Research
Aug 06, 2019
Audentes Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Jul 16, 2019
MDA Awards Venture Philanthropy Funding to Dr. Rachelle Crosbie to Develop a Novel Membrane-Stabilizing Drug for Duchenne Muscular Dystrophy
May 14, 2019
Muscular Dystrophy Association Awards 26 Grants Totaling More Than $7.5 Million for Neuromuscular Disease Research
Apr 18, 2019
Parent Project Muscular Dystrophy Awards $100,000 Grant to Nationwide Children's Hospital to Further Explore GALGT2 Gene Therapy in Duchenne Muscular Dystrophy
Feb 13, 2019
PTC Therapeutics Launches Fifth Annual STRIVE Grant Award Program for Duchenne Muscular Dystrophy
Jan 31, 2019
PTC Therapeutics Launches New Program to Support Research Projects in Rare, Genetic Disorders
Jan 24, 2019
Parent Project Muscular Dystrophy Awards $105,000 Grant to University of Missouri to Explore a Mini-Dystrophin Gene Aimed at Protecting Cardiac Function
Dec 19, 2018
Parent Project Muscular Dystrophy Awards $329,000 Grant to Binghamton University to Examine the Role of the Immune System on Dystrophin Restoration
Nov 13, 2018
Evox Therapeutics Wins Funding From Duchenne UK to Explore Exosome-Mediated Delivery of Dystrophin
Oct 15, 2018
DMD Drugs Market Size Worth $4.11 Billion by 2023 | CAGR: 41.3%: Grand View Research, Inc.